Harrow (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, today announced that it will release its financial results for the second quarter ended June 30, 2023, on Wednesday, August 9, 2023, after the market close. The Company will also post its second quarter Letter to Stockholders to the “Investors” section of its website, harrow.com. Harrow will host a conference call and live webcast at 4:45 p.m. Eastern Time to discuss the results and provide a business update.
Conference Call Details: |
||||
Date: |
Wednesday, August 9, 2023 |
|||
Time: |
4:45 p.m. Eastern time |
|||
Participant Dial-in: |
1-833-953-2434 (U.S.)
|
|||
Replay Dial-in (Passcode 3750229):
|
1-877-344-7529 (U.S.)
|
|||
Webcast: (online replay through August 9, 2024) |
||||
About Harrow
Harrow Health, Inc. (Nasdaq: HROW) is a leading eyecare pharmaceutical company engaged in the discovery, development, and commercialization of innovative ophthalmic pharmaceutical products for the U.S. market. Harrow helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans each year. For more information about Harrow, please visit harrow.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230726998269/en/
Contacts
Jamie Webb, Director of Communications and Investor Relations
jwebb@harrowinc.com
615-733-4737
